IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 mapk in a mouse macrophage cell line

American Journal of Physiology - Cell Physiology - Tập 280 Số 3 - Trang C441-C450 - 2001
Edward D. Chan1, David W. H. Riches2
1Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, and
2Program in Cell Biology, National Jewish Medical and Research Center, Denver, Colorado 80206

Tóm tắt

Nitric oxide (NO·) produced by inducible nitric oxide synthase (iNOS) mediates a number of important physiological and pathophysiological processes. The objective of this investigation was to examine the role of mitogen-activated protein kinases (MAPKs) in the regulation of iNOS and NO· by interferon-γ (IFN-γ) + lipopolysaccharide (LPS) in macrophages using specific inhibitors and dominant inhibitory mutant proteins of the MAPK pathways. The signaling pathway utilized by IFN-γ in iNOS induction is well elucidated. To study signaling pathways that are restricted to the LPS-signaling arm, we used a subclone of the parental RAW 264.7 cell line that is unresponsive to IFN-γ alone with respect to iNOS induction. In this RAW 264.7γNO(−) subclone, IFN-γ and LPS are nevertheless required for synergistic activation of the iNOS promoter. We found that extracellular signal-regulated kinase (ERK) augmented and p38 mapk inhibited IFN-γ + LPS induction of iNOS. Dominant-negative MAPK kinase-4 inhibited iNOS promoter activation by IFN-γ + LPS, also implicating the c-Jun NH2-terminal kinase (JNK) pathway in mediating iNOS induction. Inhibition of the ERK pathway markedly reduced IFN-γ + LPS-induced tumor necrosis factor-α protein expression, providing a possible mechanism by which ERK augments iNOS expression. The inhibitory effect of p38 mapk appears more complex and may be due to the ability of p38 mapk to inhibit LPS-induced JNK activation. These results indicate that the MAPKs are important regulators of iNOS-NO· expression by IFN-γ + LPS.

Từ khóa


Tài liệu tham khảo

Ajizian SJ, 1999, J Infect Dis, 179, 939, 10.1086/314659

10.1523/JNEUROSCI.18-05-01633.1998

10.1006/bbrc.1998.9857

10.1073/pnas.94.24.13169

Chan ED, 1999, J Immunol, 162, 415, 10.4049/jimmunol.162.1.415

Chen C-C, 1999, Mol Pharmacol, 55, 481

10.1074/jbc.272.45.28373

10.1074/jbc.274.23.16604

10.1016/0092-8674(94)90380-8

10.1126/science.7839144

Ding AH, 1988, J Immunol, 141, 2407, 10.4049/jimmunol.141.7.2407

10.1016/S0021-9258(19)84941-4

10.1016/S0959-437X(97)80111-6

10.1074/jbc.272.21.13484

10.1074/jbc.272.2.1226

10.1006/bbrc.1995.1472

10.1093/nar/24.9.1682

10.1074/jbc.272.12.8083

10.1126/science.7824938

10.1126/science.7914033

10.1101/gad.7.11.2135

10.1165/ajrcmb.20.5.3452

Jones CA, 1999, Am J Respir Crit Care Med, 159, A722, 10.1164/ajrccm.159.3.9803001

10.1126/science.7510419

10.1016/S0022-1759(96)00162-7

10.1038/369156a0

10.1038/372739a0

10.1126/science.7716521

10.1016/S0021-9258(18)53940-5

10.1073/pnas.90.20.9730

10.1016/S0021-9258(18)42704-4

10.1128/MCB.19.6.4289

10.1016/0092-8674(94)90268-2

10.1084/jem.180.3.977

10.1016/S0021-9258(17)37169-7

10.1084/jem.182.6.1683

10.1074/jbc.271.15.8971

10.1006/bbrc.1999.1574

10.1177/096805199600300502

10.1016/S0021-9258(17)36703-0

10.1002/jlb.54.2.171

10.1074/jbc.271.32.19025

10.1074/jbc.273.35.22800

Rose DM, 1997, J Immunol, 158, 3433, 10.4049/jimmunol.158.7.3433

10.1038/372794a0

Sawada T, 1997, J Immunol, 158, 5267, 10.4049/jimmunol.158.11.5267

10.1074/jbc.271.2.1111

10.1002/j.1460-2075.1993.tb06066.x

10.1074/jbc.273.24.15148

10.1073/pnas.76.9.4350

10.1074/jbc.271.14.8307

10.1126/science.7618106

Winston BW, 1997, J Immunol, 159, 4491, 10.4049/jimmunol.159.9.4491

Winston BW, 1995, J Immunol, 155, 1525, 10.4049/jimmunol.155.3.1525

10.1084/jem.177.6.1779

10.1126/science.1373522

10.1016/S0021-9258(17)37600-7

10.1038/372798a0

Thông tin
Thông tin xuất bản

American Journal of Physiology - Cell Physiology

Tập 280 Số 3

C441-C450

Thông tin tác giả